课题基金 / 基金详情

NEW TRITERPENOIDS FROM INDIAN PLANTS TO PREVENT CANCER

NEW TRITERPENOIDS FROM INDIAN PLANTS TO PREVENT CANCER
来自印度植物的新三萜类化合物可预防癌症
批准号:
6540797
负责人:
Michael B Sporn
金额:
$4.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2004-06-30

项目摘要

项目成果

Michael B Sporn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary goal of NIH Grant R01 CA78814-01A1 is to develop new chemical agents, called triterpenoids, for the chemoprevention of cancer. The need for new agents to prevent cancer is readily evident from the continuing worldwide high mortality rates for the common forms of cancer. In a collaborative effort between the Department of Pharmacology, Dartmouth Medical School, and the Department of Chemistry, Dartmouth College, we have already made excellent progress toward this. The project thus far has involved the joint efforts of molecular and cell biologists and organic chemists. The research strategy has been for the chemists to synthesize new triterpenoids, and then for the biologists to evaluate these new compounds for useful pharmacological activity. We now wish to extend this same approach in a highly related international collaboration, involving skilled biologists and chemists at the world-renowned Indian Institute of Science, in Bangalore, India. The proposed collaboration is modelled on the Dartmouth project. There is a major need for new triterpenoid structures to be used for drug development. The Dartmouth project is limited in its access to triterpenoids that occur as natural products in plants that are found widely in Asia. The Department of Chemistry at the Institute of Science in Bangalore has a distinguished publication record of isolating and characterizing many triterpenoids found in native Indian plants. Such agents will be used in Bangalore for two purposes: 1) they will be tested themselves as potential pharmacological agents; and 2) they will be used as a starting point for the synthesis of new drugs that will be tested in this program, in a manner similar to the Dartmouth program. Furthermore, there are excellent skills in basic molecular and cell biology in the Department of Molecular Reproduction, Development, and Genetics at the Institute in Bangalore, and investigators in that Department will also collaborate on the biological aspects of this project, again in a manner similar to the Dartmouth program. The essential feature of this proposed project will be a close collaboration and interchange of information and materials between the investigators in Bangalore and those at Dartmouth. The nature of the chemistry and biology that will be performed in Bangalore will be such that it will expand and enhance the efforts of the Dartmouth program, without duplicating or overlapping with it.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tet.2008.10.035
发表时间: 2008-12-15
期刊: Tetrahedron
影响因子: 2.1
作者: [Subba Rao GS, Kondaiah P, Singh SK, Ravanan P, Sporn MB]
通讯作者: Sporn MB
Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Glioblastoma
  • 批准号:
    10081123
  • 项目类别:
  • 资助金额:
    $39.99万
  • 财政年份:
    2020
  • 负责人:
    Michael B Sporn
  • 依托单位:
Development of the New Synthetic Triterpenoid CDDO-2P-Im for Chemoprevention of the ARDS of COVID-19
  • 批准号:
    10202843
  • 项目类别:
  • 资助金额:
    $24.98万
  • 财政年份:
    2020
  • 负责人:
    Michael B Sporn
  • 依托单位:
Conference on Roles of TGF-Beta in Disease Pathogenesis
  • 批准号:
    6887127
  • 项目类别:
  • 资助金额:
    $0.3万
  • 财政年份:
    2005
  • 负责人:
    Michael B Sporn
  • 依托单位:
Chemoprevention of Estrogen Receptor Negative Breast Cancer
  • 批准号:
    7236736
  • 项目类别:
  • 资助金额:
    $33.33万
  • 财政年份:
    2003
  • 负责人:
    Michael B Sporn
  • 依托单位:
海外基金